2,3-Dihydroxypropyl oleate

2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.

Cross Reference

Introduction

To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate

PubChem Associated disorders and diseases

What pathways are associated with 2,3-Dihydroxypropyl oleate

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 2,3-Dihydroxypropyl oleate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 2,3-Dihydroxypropyl oleate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What genes are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 2,3-Dihydroxypropyl oleate

Download all related citations
Per page 10 20 50 100 | Total 520
Authors Title Published Journal PubMed Link
Joseph JS et al. Characterization of lipid matrices for membrane protein crystallization by high-throughput small angle X-ray scattering. 2011 Methods pmid:21903166
Wallace E et al. Monoolein lipid phases as incorporation and enrichment materials for membrane protein crystallization. 2011 PLoS ONE pmid:21909395
Phan S et al. Evaluating the link between self-assembled mesophase structure and drug release. 2011 Int J Pharm pmid:21963475
Falkman P et al. Lyotropic lipid phases confined in cylindrical pores: structure and permeability. 2011 J Phys Chem B pmid:22007791
Lian R et al. Silymarin glyceryl monooleate/poloxamer 407 liquid crystalline matrices: physical characterization and enhanced oral bioavailability. 2011 AAPS PharmSciTech pmid:21948306
Zhai J et al. Revisiting β-casein as a stabilizer for lipid liquid crystalline nanostructured particles. 2011 Langmuir pmid:22026367
Montenegro L et al. In vitro evaluation of idebenone-loaded solid lipid nanoparticles for drug delivery to the brain. 2011 Drug Dev Ind Pharm pmid:21204752
Alam MM et al. Kinetics of low pH-induced lamellar to bicontinuous cubic phase transition in dioleoylphosphatidylserine∕monoolein. 2011 J Chem Phys pmid:21495771
Nguyen TH et al. Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administration. 2011 J Control Release pmid:21497623
Liu Y et al. Preparation and evaluation of glyceryl monooleate-coated hollow-bioadhesive microspheres for gastroretentive drug delivery. 2011 Int J Pharm pmid:21540088
Trickler WJ et al. Antitumor efficacy, tumor distribution and blood pharmacokinetics of chitosan/glyceryl-monooleate nanostructures containing paclitaxel. 2011 Nanomedicine (Lond) pmid:21542683
Dong YD et al. Adsorption of nonlamellar nanostructured liquid-crystalline particles to biorelevant surfaces for improved delivery of bioactive compounds. 2011 ACS Appl Mater Interfaces pmid:21506614
Ghosh S et al. Comparison of Pickering and network stabilization in water-in-oil emulsions. 2011 Langmuir pmid:21528852
Jin J et al. Production of diacylglycerols from glycerol monooleate and ethyl oleate through free and immobilized lipase-catalyzed consecutive reactions. 2011 N Biotechnol pmid:20951847
Tilley A et al. Transfer of lipid and phase reorganisation in self-assembled liquid crystal nanostructured particles based on phytantriol. 2011 Phys Chem Chem Phys pmid:21240427
Rizwan SB et al. Preparation of phytantriol cubosomes by solvent precursor dilution for the delivery of protein vaccines. 2011 Eur J Pharm Biopharm pmid:21237267
Kulkarni CV et al. Monoolein: a magic lipid? 2011 Phys Chem Chem Phys pmid:21183976
Achrai B et al. Solubilization of gabapentin into HII mesophases. 2011 J Phys Chem B pmid:21182317
Kwon TK and Kim JC Complex coacervation-controlled release from monoolein cubic phase containing silk fibroin and alginate. 2011 Biomacromolecules pmid:21190340
Amar-Zrihen N et al. Food volatile compounds facilitating HII mesophase formation: solubilization and stability. 2011 J. Agric. Food Chem. pmid:21495722